Sort
23,748 grants matching “melanoma”
Regulation of Tumorigenesis by the Perk Kinase
$258,649J. Alan Diehl · University Of Pennsylvania · P01 · FY2015 · CA
Regulation of Tumorigenesis by the Perk Kinase
$258,649J. Alan Diehl · University Of Pennsylvania · P01 · FY2016 · CA
ECM MATRIX, PROTEASE AND MELANOMA PROLIFERATION
$258,640Yves A Declerck · Children'S Hospital Of Los Angeles · R01 · FY2006 · CA
Regulation of Tumorigenesis by the Perk Kinase
$258,637J. Alan Diehl · University Of Pennsylvania · P01 · FY2018 · CA
Regulation of Tumorigenesis by the Perk Kinase
$258,629J. Alan Diehl · University Of Pennsylvania · P01 · FY2017 · CA
KiSS1 and Its G-Protein Coupled Receptor in Metastasis
$258,626Texas A&M University Health Science Ctr · R01 · FY2005 · CA
DAP-2 Regulation By Notch In Drosophila Leg Development
$258,537Pennsylvania State University-Univ Park · R01 · FY2001 · GM
Reversal of regulatory T cell function in prostate cancer
$258,529Rongfu Wang · Baylor College Of Medicine · R01 · FY2008 · CA
Reversal of regulatory T cell function in prostate cancer
$258,529Rongfu Wang · Baylor College Of Medicine · R01 · FY2007 · CA
Reversal of regulatory T cell function in prostate cancer
$258,529Rongfu Wang · Baylor College Of Medicine · R01 · FY2009 · CA
Immunomodulating Ruthenium Metal Complexes for Melanoma Photodynamic Therapy
$258,455Sherri McFarland · University Of North Carolina Greensboro · R01 · FY2019 · CA
NHGRI/DIR Microarray Core
$258,436Elaine Ostrander · National Human Genome Research Institute · ZIC · FY2013 · HG
Polymer Based Gene Delivery
$258,376Alexander V Kabanov · University Of Nebraska Medical Center · R01 · FY2006 · CA
Treatment of Melanoma with Optimzed Peptide Vaccines
$258,324Esteban Celis · Augusta University · R01 · FY2013 · CA
MECHANISM OF T CELL ANERGY INDUCED BY BREAST CANCER
$258,309New York University School Of Medicine · R01 · FY2000 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$258,301Indiana Univ-Purdue Univ At Indianapolis · U10 · FY2001 · CA
Regulatory T Cells and Toll-Like Receptor Signaling in Lymphoma Therapy
$258,282Wang Rongfu · Baylor College Of Medicine · P50 · FY2008 · CA
Cell-Cell Communication During Melanoma Development
$258,214Meenhard Herlyn · Wistar Institute · R01 · FY2006 · CA
Metabolic Phenotyping with PET to Monitor and Predict Response to Kinase
$258,182Johannes Czernin · University Of California Los Angeles · P50 · FY2007 · CA
Changes of CD4+ Lymphocyte Profile in Patients with Renal Cell Carcinoma and its
$258,178Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · CA
Metabolic Phenotyping with PET to Monitor and Predict Response to Kinase
$258,131Johannes Czernin · University Of California Los Angeles · P50 · FY2008 · CA
Southwest Oncology Group
$258,128Heinz Josef Lenz · University Of Southern California · U10 · FY2006 · CA
Optimization of Melanoma Vaccine with T Helper Epitope
$258,118Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · CA
Administration and Clinical Trials
$258,116Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2016 · CA
Recombinant Carcinoembryonic Antigen as a PET Reporter Gene
$258,098Anna M Wu · University Of California Los Angeles · P50 · FY2007 · CA